| Literature DB >> 32646382 |
Elise Crayton1, Michelle Richardson2, Chris Fuller3, Catherine Smith3, Sunny Liu4, Gillian Forbes4, Niall Anderson4,5, Laura Shallcross3, Susan Michie4,5, Andrew Hayward6, Fabiana Lorencatto4,5.
Abstract
BACKGROUND: Overuse of antibiotics has contributed to antimicrobial resistance; a growing public health threat. In long-term care facilities, levels of inappropriate prescribing are as high as 75%. Numerous interventions targeting long-term care facilities' antimicrobial stewardship have been reported with varying, and largely unexplained, effects. Therefore, this review aimed to apply behavioural science frameworks to specify the component behaviour change techniques of stewardship interventions in long-term care facilities and identify those components associated with improved outcomes.Entities:
Keywords: Antimicrobial stewardship; Behavioural sciences; Nursing homes; Systematic review
Mesh:
Substances:
Year: 2020 PMID: 32646382 PMCID: PMC7350746 DOI: 10.1186/s12877-020-01564-1
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Fig. 2PRISMA flow diagram
Fig. 1Example of intervention type and component behaviour change technique extraction and coding
Study characteristics and intervention effects
| First author/ Country | Design | Measurement method of behaviour | Antibiotics Assessed | Comparison/ control | Behavioural outcomes | Reported statistics | 95% CI | Intervention promise | Risk of Bias |
|---|---|---|---|---|---|---|---|---|---|
| Monette 2007/ Canada [ | cRCT [8 LTCFs] | Not reported | Not reported | Usual care | Adherence to guidelines post-intervention 1(3-month period) | OR = 0,47 | 0.21, 1.05 | Very | Unclear |
| Adherence to guidelines post-intervention 2 (3-month period) | OR = 0.36 | 0.18, 0.73 | |||||||
| Adherence to guidelines follow up (3-month period) | OR = 0.48 | 0.23, 1.02 | |||||||
| Naughton 2001/ US [ | RCT [10 LTCFs] | Form completion | Not reported | Pre-intervention | Antibiotic use consistent with guideline | OR = NR | NR | Not | Low |
| Jump 2013/ US [ | Clinical Demonstration Project [1 LTCF] | Chart review | Not reported | None | Relationship between referral source (LTCF or ID consultation service) and likelihood of needing an intervention (stewardship behaviour) [adjusted OR] | OR = 0.4 | 0.19, 0.78 | Very | Critical |
| McMaughan 2016/ US [ | Pre-post test with comparison [12 LTCFs] | Chart review | Not reported | Comparison-no description provided | Relationship between group allocation and prescription being written: High intensity decision aid training | OR = 0.77 | 0.32, 1.86 | Not | Serious |
| Relationship between group allocation and prescription being written: Low intensity decision aid training | OR = 1.19 | 0.47, 3.01 | |||||||
| Pre/post intervention comparison: high intensity decision aid training | OR = 0.79 | 0.33, 1.88 | |||||||
| Pre/post intervention comparison: Low intensity decision aid training | OR = 0.63 | 0.25, 1.60 | |||||||
| Van Buul 2015/ Netherlands [ | Quasi-experimental [10 LTCFs] | Form completion | Not reported | Comparison-no description provided | Overall appropriateness of antibiotic prescribing | OR = 0.76 | 0.43, 1.34 | Not | Serious |
| Appropriateness of antibiotic prescribing for UTI | OR = 0.74 | 0.39, 1.40 | |||||||
| Appropriateness of antibiotic prescribing for RTI | OR = 0.95 | 0.39, 2.33 | |||||||
| Petterson 2011/ Sweden [ | cRCT [46 LTCFs] | Survey/ questionnaire | Quinolones Nitrofurantoin | Comparison-no description provided | Proportion of quinolones prescribed for lower UTI | Β = 0.028 | − 0.193, 0.249 | Quite | High |
| Proportion of antibiotics prescribed | Β = 0.124 | − 0.228, − 0.019 | |||||||
| Proportion of nitrofurantoin prescribed for lower UTI | Β = − 0.077 | −0.242, 0.088 | |||||||
| Schwartz 2007/ US [ | Quasi-experimental [1 LTCF] | Chart review | Not reported | None | Effect of intervention on incidence of antimicrobial days | Β = −0.04 | NR | Very | Moderate |
| Effect of intervention on incidence of antimicrobial starts | Β = −0.05 | NR | |||||||
| Loeb 2005/ Canada & US [ | cRCT [20 LTCFs] | Form completion | Not reported | Usual care | Rate of antimicrobial use for suspected UTI | t = − 0.49 | −0.93, − 0.06 | Quite | High |
| Total antimicrobial use between the intervention and usual care groups | t = − 0.37 | −1.17, 0.44 | |||||||
| Kassett 2016/ Canada [ | Pre-post test [1 LTCF] | Medical record review | Amikacin Amoxicillin Amoxicillin– clavulanic acid Ampicillin Ceftriaxone Ciprofloxacin Gentamicin Levofloxacin Meropenem Nitrofurantoin Norfloxacin Piperacillin and tazobactam Tobramycin Trimethoprim (TMP) Trimethoprim–sulfamethoxazole (TMP-SMX) | None | UTI rate (an index of overall antibiotic use) | t = 1.255 d = 0.535 | −0.003, 0.013 | Quite | Serious |
| Prescribed days of therapy | t = 2.293 d = 0.978 | 0.003, 0.066 | |||||||
| Actual days of therapy | t = 2.902 d = 1.237 | 0.011, 0.065 | |||||||
| Ciprofloxacin rate (number of ciprofloxacin prescriptions in a given month per LTCF unit occupancy for that month) | t = 3.79 d = 1.616 | 0.003, 0.012 | |||||||
| Ciprofloxacin proportion (number of ciprofloxacin prescriptions in a given month per UTI case) | t = 3.809 d = 1.624 | 0.064, 0.216 | |||||||
| Doernberg 2015/ US [ | Quasi-experimental [3 LTCFs] | Chart review | Fluoroquinolones Nitrofurantoin Trimethoprimsulfamethoxazole Cephalexin Amoxicillin +/− clavulanate | None | Antibiotic starts for UTI (per 1000 resident-days) | IRR = 0.94 | 0.92, 0.97 | Very | Serious |
| All antibiotic starts (per 1000 resident-days) | IRR = 0.95 | 0.92, 0.98 | |||||||
| Zimmerman 2014/ US [ | Quasi-experimental [12 LTCFs] | Infection control log review | Not reported | Comparison-no description provided | Overall intervention effectiveness | IRR = 0.71 | 0.56, 0.90 | Very | Moderate |
| Antibiotic prescribing (prescriptions per resident-day) [adjusted model] | IRR = 0.86 | 0.79, 0.95 | |||||||
| Fleet 2014/ UK [ | cRCT (pilot) [30 LTCFs] | Not reported | Amoxicillin Co-amoxiclav Flucloxacillin Trimethoprim Clarithromycin Cefalexin Erythromycin Nitrofurantoin Ciprofloxacin Doxycycline Other | Control- no description provided | Pre- and post-intervention point prevalence of systemic antibiotic prescribing (per 100 residents) for treatment of infection - Intervention Group | EPR = 1.01 | 0.81, 1.25 | Quite | Low |
| Pre- and post-intervention point prevalence of systemic antibiotic prescribing (per 100 residents) for treatment of infection - Control Group | EPR = 1.11 | 0.87, 1.41 | |||||||
Total antibiotic consumption (defined daily does (DDDs)/1000 residents/day (DRD)) - Intervention group | % decrease = 4.9% (3.25 DRD) | 1.0, 8.6% | |||||||
| Total antibiotic consumption (defined daily does (DDDs)/1000 residents/day (DRD)) - Control group | % increase = 5.1% (2.24 DRD) | 0.2, 10.2% | |||||||
| Furuno 2014/ US [ | Pre-post test [1 LTCF] | Semi-structured interview and chart review | Aminoglycosides Carbapenems Cephalosporins Fluoroquinolones Vancomycin Trimethoprim-sulfamethoxazole Tetracyclines Nitrofurantonin Metronidazole Other | None | Appropriate empirical antibiotic prescribing | % Increase: 32 to 45% | NR | Not | Serious |
| Gugkaeva 2012/ US [ | Phase 1 observational Phase 2 interventional [1 LTCF] | Medical record review | Not reported | None | Cases where antibiotics were prescribed inappropriately (comparison pre and post intervention implementation) | % Decrease: 40 to 21% | NR | Quite | Serious |
| Hutt 2006/ US [ | Pre-post test [2 LTCFs] | Nursing home record review: - A modified Barthel Index -Cognitive Performance Scale -NHAP Severity Index -Measures of intervention dose | Not reported | Control- no description provided | Compliance to guideline: Timely antibiotics - Intervention Group [change in percentage points] | −9 | NR | Quite | Serious |
| Compliance to guideline: Timely antibiotics - Control Group [change in percentage points] | −53 | NR | |||||||
| Compliance to guideline: Appropriate antibiotics - Intervention Group [change in percentage points] | 18 | NR | |||||||
| Compliance to guideline: Appropriate antibiotics - Control Group [change in percentage points] | −13 | NR | |||||||
| Average total compliance to guidelines score – intervention group [change in percentage points] | 5 | NR | |||||||
| Average total compliance to guidelines score – intervention group [change in percentage points] | −5 | NR | |||||||
| Linnebur 2011/ US [ | Quasi-experimental [16 LTCFs] | Medical record review | Levofloxacin Azithromycin Other | Control-no description provided | Providing antibiotics within 4 h - Intervention group [change in % from baseline to 2 years] | 57 to 75% | NR | Quite | Critical |
| Providing antibiotics within 4 h - Control group [change in % from baseline to 2 years] | 38 to 31% | NR | |||||||
| Adherence to optimal antibiotic use - Intervention group [change in % from baseline to 2 years] | 60 to 66% | NR | |||||||
| Adherence to optimal antibiotic use - Control group [change in % from baseline to 2 years] | 32 to 39% | NR | |||||||
| Receipt of antibiotics for 10 to 14 days - Intervention group [change in % from baseline to 2 years] | 27 to 13% | NR | |||||||
| Receipt of antibiotics for 10 to 14 days - Control group [change in % from baseline to 2 years] | 24 to 19% | NR | |||||||
| Rahme 2016/ US [ | Pre-post test [1 LTCF] | Form completion (inventory usage reports) | Fluoroquinolone Nitrofurantoin Ciprofloxacin Levofloxacin Moxifloxacin Penicillin Cephalosporin Macrolide Tetracycline Sulfonamide | None | Total antibiotic use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | −11.68% | −0.44, −18.97 | Quite | Low |
| Penicillin use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | + 10.23% | −5.15, 1.21 | |||||||
| Cephalosporins use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | −24.49% | −0.15, 6.41 | |||||||
| Macrolides use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | −25.63% | −1.25, 4.50 | |||||||
| Tetracyclines use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | −14.29% | −3.10, 9.48 | |||||||
| Fluoroquinolones use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | −16.20% | −2.38, 6.78 | |||||||
| Sulfonamides use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | + 9.45% | −2.02, 0.30 | |||||||
| Nitrofurantoin use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | −25.34% | −0.34, 1.33 | |||||||
| Ciprofloxacin use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | −38.7% | 0.58, 4.9 | |||||||
| Levofloxacin use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | + 9.09% | −3.21, 2.09 | |||||||
| Moxifloxacin use (daily defined dose (DDD) per 1000 resident days (RD) [pre/post intervention percentage change] | −5.88% | −0.32, 0.34 | |||||||
| Smith 2016/ US [ | Pre-post test [1 LTCF] | Chart review | Vancomycin | None | Compliance with vancomycin level monitoring | % Increase: 71–85% | NR | Quite | Low |
| Vancomycin trough levels in therapeutic range | % Increase: 63.3–70.5% | NR | |||||||
| Hutt 2011/ US [ | Quasi-experimental [16 LTCFs] | Chart review | Not reported | Control- no description provided | Year 1 Adherence to guideline for treating stable residents in the NH | M = 95 [approx.] | NR | Quite | Serious |
Year 2 Adherence to guideline for treating stable residents in the NH | M = 98 [approx..] | NR | |||||||
| Zabarsky 2008/ US [ | Quasi-experimental [1 LTCF] | Not reported | Not reported | None | 3 months Pre-intervention: rate of asymptomatic bacteria treated [per 1000 patient-days] | IRR = 1.7 | 1.1, 2.6 | Very | Moderate |
| 6 months Post-intervention: rate of asymptomatic bacteria treated [per 1000 patient-days] | IRR = 0.6 | 0.4, 1.0 | |||||||
| 7 to 30 months Post-intervention: rate of asymptomatic bacteria treated [per 1000 patient-days] | IRR = 0.3 | 0.2, 0.4 | |||||||
| 3 months Pre-intervention: total antimicrobial days of therapy [per 1000 patient-days] | 167.7 | NR | |||||||
| 6 months Post-intervention: total antimicrobial days of therapy [per 1000 patient-days] | 117.4 | NR | |||||||
| 7 to 30 Months post-intervention" total antimicrobial days of therapy [per 1000 patient-days] | 109.0 | NR |
IRR Incidence rate ratios; d-Cohen’s d effect size, OR Odds ratio, M Mean, EPR Estimated prevalence rate, t t-test statistic; −Beta coefficient, UTI Urinary tract infection, NR Not reported, CI confidence interval
Sample size reports upon the sample included in the analysis only
Studies categorised by target, action, context, timeframe and actor
| Study | Target (whom) | Action (behaviour) | Context | Timeframe | Actor (whose behaviour) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Physicians | Nurses | Physician Assistants | Nurses Assistants | Pharmacists | Medical Directors | Patients | Family Members | Infection Control Practitioners | Other Unspecified | |||||
| Monette 2007 [ | UTI LRTI SSTI | Antibiotic prescribing | LTCF | Unspecified | – | ✓ | – | – | – | – | – | – | – | – |
| Petterson 2011 [ | UTI | Antibiotic prescribing | Nursing home | Unspecified | ✓ | ✓ | – | – | – | – | – | – | – | – |
| Loeb 2005 [ | UTI | Antibiotic prescribing | Nursing home | Unspecified | ✓ | ✓ | ✓ | – | – | – | – | – | – | – |
| Naughton 2001 [ | NHAP | Antibiotic prescribing | Skilled nursing facility | Unspecified | ✓ | ✓ | – | ✓ | – | – | – | – | – | – |
| McMaughan 2016 [ | UTI | Antibiotic prescribing | Nursing homes | Unspecified | – | – | – | – | – | – | – | – | – | ✓ |
| Schwartz 2007 [ | UTI | Antibiotic prescribing | LTCF | Unspecified | ✓ | ✓ | – | – | – | – | – | – | – | ✓ |
| Kassett 2016 [ | UTI | Antibiotic prescribing | LTCF | Unspecified | ✓ | ✓ | – | – | ✓ | – | ✓ | ✓ | – | – |
| Doernberg 2015 [ | UTI | Antibiotic prescribing | LTCF | Unspecified | – | – | – | – | – | – | – | – | ✓ | – |
| Fleet 2014 [ | LRTI SSTI UTI | Antibiotic prescribing | Nursing home | Unspecified | – | ✓ | – | – | – | – | – | – | – | – |
| Furuno 2014 [ | Unspecified | Antibiotic prescribing | Skilled nursing facility | Unspecified | – | – | – | – | – | – | – | – | – | ✓ |
| Gugkaeva 2012 [ | Unspecified | Antibiotic prescribing | Nursing home | Unspecified | – | – | – | – | – | – | – | – | – | ✓ |
| Hutt 2006 [ | NHAP | Antibiotic prescribing | Veterans nursing home | Unspecified | ✓ | ✓ | – | ✓ | – | – | – | – | – | – |
| Linneburr 2011 [ | LRTI | Adherence to guidelines | Nursing homes | Unspecified | ✓ | – | ✓ | ✓ | – | ✓ | – | – | – | – |
| Rahme 2016 [ | UTI SSRI RTI | Antibiotic prescribing | LTCF | Unspecified | – | – | – | – | – | – | – | ✓ | – | ✓ |
| Hutt 2011 [ | LRTI | Adherence to guidelines | Nursing home | Unspecified | ✓ | ✓ | ✓ | – | – | ✓ | – | – | – | – |
| Jump 2013 [ | Unspecified | Enacting stewardship role | Veteran Affairs community living centre | Unspecified | – | – | – | – | – | – | – | – | – | ✓ |
| Van Buul 2015 [ | UTI RTI | Antibiotic prescribing | Nursing home | Unspecified | ✓ | ✓ | – | – | – | – | – | – | – | – |
| Zimmerman 2014 [ | UTI SSTI RTI | Antibiotic prescribing | Nursing home | Unspecified | – | – | – | – | – | – | ✓ | ✓ | – | ✓ |
| Smith 2016 [ | Unspecified | Monitoring of AKI and vancomycin trough levels | Nursing home | When indicated | – | – | – | – | ✓ | – | – | – | – | – |
| Zabarsky 2008 [ | UTI | Antibiotic prescribing | Nursing home | Unspecified | ✓ | ✓ | ✓ | – | – | – | – | – | – | ✓ |
TACTA Target, Action, Context, Timeframe, Actor UTI-Urinary Tract Infection, LRTI Lower Respiratory Tract Infection; RTI-Respiratory Tract Infection; SSTI- Skin and Soft Tissue Infection; NHAP-Nursing Home Acquired Pneumonia
Intervention types - definitions, examples, frequency and association with intervention outcomes
| Intervention Type | Definition | Example | No. used in very promising intervention | No. used in quite promising interventions | No. used in not promising interventions | Total no. of times used across all interventions | Promise ratio |
|---|---|---|---|---|---|---|---|
| Providing feedback on prescribing e.g. sending prescribing profiles for the previous 3 months to prescribers at intervention sites [ | 7 | 8 | 4 | 19 | 3.75 | ||
| Guidelines stating the recommended empirical antibiotic to be administered [ | 7 | 6 | 3 | 16 | 4.33 | ||
| Delivering training sessions on how to use algorithms to support antibiotic prescription decision making [ | 3 | 4 | 2 | 9 | 3.5 | ||
| Training sessions providing hypothetical case scenarios demonstrating the behaviour [ | 1 | 3 | 0 | 4 | – | ||
| Assigning a team member to a new role [ | 6 | 7 | 4 | 17 | 3.25 | ||
| Payment to intervention facilities to incentivise compliance to guidelines [ | 0 | 1 | 0 | 1 | – | ||
| Enforcing mandatory attendance to training on antimicrobial prescribing [ | 0 | 1 | 0 | 1 | – | ||
| Using credible sources (such as colleagues perceived to be experts in infectious diseases) to reinforce messages from training, education sessions or guidelines [ | 7 | 3 | 2 | 12 | 5 |
Definitions from [41].
Fig. 3Frequency of each intervention type’s association with very, quite and not promising interventions
Fig. 4Frequency of each behaviour change technique’s association with very, quite and not promising interventions
BCTs - definitions, examples, frequency and association with intervention outcomes
| BCT | Definition | Example | No. used in very promising intervention | No. used in quite promising interventions | No. used in not promising interventions | Total no. of times used across all interventions | Promise ratio |
|---|---|---|---|---|---|---|---|
“presented local pre-test prescribing in comparison with overall pre-test data and qualitative data on factors influencing antibiotic prescribing behaviour.” [ | 5 | 3 | 1 | 9 | 8 | ||
| “individualized direct feedback regarding specific instances when inappropriate urine cultures were sent and when ASB was treated” [ | 4 | 0 | 0 | 4 | – | ||
| ““a 60-min presentation summarizing treatment recommendations” [ | 7 | 7 | 4 | 18 | 3.5 | ||
| “education was provided regarding the potential adverse effects of unnecessary antibiotic use, including promotion of antibiotic resistance,” [ | 2 | 2 | 1 | 5 | 4 | ||
| “Posters and other promotional material such as bookmarks were also distributed” [ | 2 | 5 | 0 | 7 | – | ||
| “pharmacists did not interfere with antibiotic prescribing, but collected data on antibiotics prescribed, duration of therapy, laboratory tests, signs and symptoms of infection, and culture and sensitivity results” [ | 0 | 2 | 0 | 2 | – | ||
| “stimulated interactions between the participants” [ | 1 | 3 | 0 | 4 | – | ||
| “the introduction of the RAMP antimicrobial stewardship tool” [ | 4 | 6 | 3 | 13 | 3.33 | ||
| “prompted to … identify barriers to implementation, to develop strategies for addressing those barriers, and to discuss and clarify their role in implementation” [ | 0 | 2 | 2 | 4 | 1 | ||
“the intervention facilities were paid an additional $1000 each year during the 2 intervention years to incentivize guideline compliance” [ | 0 | 1 | 0 | 1 | – | ||
| “the providers were given a telephone number for both the infectious diseases physician on call and the antibiotic stewardship pharmacist. They were informed that this number could be called 24 h a day 7 days a week for any infectious disease related questions” [ | 3 | 3 | 0 | 6 | – | ||
| “The homes identified a study liaison nurse who was the facility’s change agent for the study” [ | 2 | 5 | 1 | 8 | 7 | ||
| “We asked the nurses to complete a one page log of presenting symptoms and signs for every resident in whom urinary tract infection was suspected, as a reminder to use the algorithms.” [ | 2 | 2 | 0 | 4 | – | ||
| “results of specimens/swabs or ‘not available yet’ or ‘none taken’ recorded; outcome of antibiotic treatment documented” [ | 0 | 1 | 0 | 1 | – | ||
| “use of antibiograms” [ | 1 | 0 | 2 | 3 | 0.5 | ||
| “The LID consultation service consisted of an infectious disease physician and nurse practitioner” [ | 7 | 3 | 2 | 12 | 5 | ||
| “the identification of opportunities for improved practice (i.e. planning action)” [ | 0 | 0 | 1 | 1 | – | ||
| “Change to default stop dates for some antibiotics - simplified access to guidelines on computers” [ | 0 | 2 | 0 | 2 | – | ||
| “Residents, their family members, and other NH staff received an informational brochure related to antibiotic prescribing and the QI program, and many attended family night gatherings or a resident council meeting or health fair where this information was presented” [ | 1 | 1 | 0 | 2 | – |
BCT Behavioural Change Technique, No. Number
aDefinitions from [42].